Synthesis and Biological Activity of 3-Aryl-5-(aryloxymethyl)-1,2,4-oxadiazoles
A. A. Shetnev,E. A. Vasilieva,I. K. Proskurina,A. S. Forostyanko,S. I. Presnukhina,M. V. Tarasenko,A. S. Lebedev,S. A. Ivanovskii,A. D. Kotov
DOI: https://doi.org/10.1134/S1070428022030071
2022-04-15
Russian Journal of Organic Chemistry
Abstract:A preparative procedure has been developed for the synthesis of a series of new medicinally relevant 3-aryl-5-(aryloxymethyl)-1,2,4-oxadiazoles in 46–66% yields by alkylation of substituted phenols with 3-aryl-5-(chloromethyl)-1,2,4-oxadiazoles in the system K 2 CO 3 /KI/DMF. Poorly studied 3-R-4 H -1,2,4-oxadiazin-5(6 H )-ones were synthesized by a new method based on the reaction of methyl chloroacetate with amidoximes in the superbasic system t -BuONa/DMSO. The synthesized compounds at concentrations of up to 250 μg/mL showed no antibacterial activity against sensitive strains of Staphylococcus aureus , Bacillus subtilis , Escherichia coli , and Pseudomonas fluorescens , which supposedly suggests their low toxicity for human intestinal and mucous microflora.
chemistry, organic